Summary of Benefit Documents
You may now view Summary of Benefit documents for Group Health members via our secure provider website. The root cause affecting the "view" capability has now been fixed.
See the latest updates, effective June 1, 2016.
See Clinical Pearls recommendations you can integrate into your practice.
See monthly clinical practice and business updates.
HEDIS information, provider reconsiderations, updated cancer guideline, and more.
Non-Medicare Drug List updated June 1.
Updated policy for reimbursement of fetal non-stress tests.
Effective Aug. 8, Elotuzumab (Empliciti™) will be added to the non-Medicare list of injectable drugs requiring prior authorization.
Group Health's quick reference guide of common HEDIS measures includes newly issued statin measures for patients with cardiovascular disease and diabetes.
Information about drugs empagliflozin, zetia and PCSK9 inhibitors, antibiotics for acute otitis media in children, and proton pump inhibitors.
Modifiers Payment Policy (PDF)
See updated information on the P3, P4, and P5 modifiers. These do not impact reimbursement.
Highlights from the March 9 meeting.
See what's offered, which services require preauthorization, and get information about claims submissions.
Group Health does not separately reimburse CAD for mammography services for all commercial members.
Updates to our guidelines, services, provider manual, and other important information.
For questions about your existing account, call OHP technical support at 1-800-973-4797.
Don't have an account? Visit OneHealthPort for more information.
Change to Your Practice?
Group Health Appointment Access Standards